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The "Swirling" Pattern of Atrial Spontaneous Echo
Contrast can be Characterized by Integrated
Backscatter Using Fourier Analysis
R. Daniel Murray, Allan L. Klein, Shalabh Chandra, Richard A. Grimm, Ian W. Black,
Annitta Morehead, William J. Stewart, James D. Thomas. The Cleveland Clinic,
Cleveland, OH
Usefulness of Contrast Transesophageal
Echocardiography in Identification of Increased
Risk of Cardiogenic Embolism in Nonvalvular
Atrial Fibrillation
Atrial spontaneous echo contrast (smoke) refers to dynamic smoke-like
echos that has both increased intensity and a distinctive "swirling" pat-
tern. We have previously shown that smoke can be measured by integrated
backscatter (IBS) intensity, and now hypothesize that the swirling pattern
could be characterized by frequency spectrum analysis of IBS sequences by
Fast Fourier Transformation (FFT).
Methods: We acquired IBS sequences during TEE in 25 pts. who had been
qualitatively assessed independently for smoke severity. We analyzed IBS
intensity of the LA smoke region, as well as reference intensity sequences
from the left ventricular cavity (LV) and the interatrial septum (lAS), for 60
consecutive frames at 30 Hz under optimal imaging gains. We calculated
FFT centroid frequencies to characterize the shape and distribution of the
frequency pattern for all acquired IBS sequences.
Hisaki Morita, Sadaichi Okumoto, Koichi Hirabayashi, Katsufumi Mizushige,
Hirohlde Matsuo. Kagawa Medical School, Kagawa, Japan
Anatomical and functional informations about the left atrial appendage (LAA)
obtained by transesophageal echocardiography (TEE) are contributory to
evaluate a risk of cardiogenic embolism (CE) in nonvalvular atrial fibrilla-
tion (NVAF). This study was designed to further characterize a subgroup
of NVAF pts with an increased risk of CE with the use of contrast TEE. In
33 NVAF pts, 15 were complicated by CE and 18 were not. Twelve age-
matched healthy subjects were studied as control. Albunex 0.1 ml/kg was
injected intravenously and the contrast echo enhancement in the left atrium
was recorded by TEE on a video tape. Non opacified area in LAA (Ao) and
LAA area were measured in end-systole, and the ratio of Ao to LAA area
(Ao ratio) was obtained as a mean of 5 consecutive measurements. Results:
In healthy subjects, the contrast agent produced complete opacification of
LAA, thus Ao ratio was 0%. While, Ao ratio was 52 ± 9% and 31 ± 6% in
NVAF with CE and without CE, respectively (p < 0.001). Ao ratio over 40%
was 80% sensitive and 78% specific for identifying CE group, and the posi-
tive predictive value was 75%. Conclusion: In NVAF, the echo contrast agent
did not opacify LAA entirely. Non opacified area of transpulmonary contrast
agent in LAA as measured by TEE, probably reflecting the extent of blood
stagnation in LAA more directly, may be a new useful index for identification
of a subgroup of NVAF pts with an increased risk of CEo
Transesophageal Echocardiographic and Clinical
Predictors for Outcome of Cardioversion of Atrial
Fibrillation
Patrick M.J. Verhors!, Roelof C. Welling, Otto Kamp, Cees A. Visser. Free Unive,sity
Hospital, Amsterdam, NL
Cost-Effectiveness of Early Cardioversion Guided
by Transesophageal Echocardiography for
Hospitalized Patients with Atrial Fibrillation
Todd B. Seto, Deborah A. Taira, Joel Tsevat, Warren J. Manning. Beth Israel Hospital,
West Roxbury VA Medical Center, and Harvard School of Public Health, Boston, MA
Transesophageal echo (TEEl-guided early cardioversion has been proposed
as a strategy for hospitalized patients with new atrial fibrillation IAF). Such an
approach would serve to minimize the cost/risk of anticoagulation and elimi-
nate the need for a second hospitalization for cardioversion at the cost/risk of
TEE. To evaluate the cost-effectiveness of the TEE approach, we examined
the cost per quality-adjusted life year (OALY) for 4 strategies: I) anticoagu-
lation for 1 mo followed by cardioversion; III transthoracic echo (TIE) and 1
mo anticoagulation followed by cardioversion; III) TIE, with TEE if TIE (-);
1 mo anticoagulation if TIE (+) or TEE (+); and IV) no TIE; initial TEE with
1 mo anticoagulation if TEE (+); early cardioversion if TEE (-). All strategies
are assumed to include 1 mo of anticoagulation following cardioversion. The
baseline assumed risk of thromboembolism was 0.8% for all strategies. The
hemorrhagic risk was assumed at 0.96% for the first mo and 0.32% the sec-
ond mo of anticoagulation. We used costs rather than hospital charges.
Results: TEE-guided early cardioversion [without initial TIE; Strategy IV]
dominates all other strategies in that it is the least costly and most effec-
tive. Current conventional therapy [Strategy II] costs over $400/pt more, with-
out change in OALY. Sensitivity analysis indicates that the hemorrhagic risk
drives the analysis, but the results are stable over a broad range of risks
and costs, including a 2/3rds reduction in the hemorrhagic complication rate.
There would also be no change in the outcome if the initial TIE were elimi-
nated from conventional therapy.
Conclusion: TEE-guided early cardioversion {without initial TIEl is both the
least expensive and the most effective strategy for hospitalized patients with
new AF. Future trials studying the use of TEE for treatment of new AF should
consider elimination of the initial TIE study and careful assessment of hem-
orrhagic complications.
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To determine the value of transesophageal echo (TEE) and clinical variables
in predicting outcome of cardioversion (CVI. we studied 62 patients with non-
valvular atrial fibrillation (AFI. who underwent TEE prior to elective electrical
CV We measured left atrial (LA) size, mitral valve annulus (MVA) width, LA
appendage (LAA) size and LAA peak flow velocity (pfv), and evaluated pres-
ence of LA spontaneous contrast (LASC) and severity (none-mild/moderate-
severe) of MV regurgitation (MVR). After CV, sinus rhythm (SR) was restored
in 50 patients (81 %) and maintained in 29 patients (58%) at 1 year follow-up.
Results:
Smoke
Initial Outcome 1 Year Outcome
AF (n ~ 12) SR In ~ 501 AF (n ~ 21) SR (n ~ 29)
LA size (cm21 23.3 ± 7.4 22.6 ± 67 26.4 ± 5.0 198 ± 6.5
MVA width (em) 3.8 ± 0.3 3.9 ± 03 4.0 ± 0.2 37 ± 0.3
LAA size (cm2 ) 7.8 ± 2.7 8.8 ± 39 9.3 ± 33 84 ± 3.3
LAA-pfv (cm/s) 22 ± 9 29 ± 15 19 ± 8 36 ± 15
LASC presence 5 17 13 4
MVR severity 7/5 38/12 16/5 22/7
'p < 0.0001, "p < 0.005
Outcome was not related to age, gender, etiology of AF, or use of anti-
arrhythmic drugs. In contrast, duration of AF was of influence on 1 year out-
come: AF vs. SR: 6.7 ± 7.3 vs. 2.0 ± 2.4 months; (**1.
Conclusions:
No TEE or clinical variables predict initial success of CV of AF. However,
1 year after initial success, LA size, MVA width, LASC, duration of AF, and




Results: Mild and severe LA smoke IBS sequences were characterized
by low dominant frequency with high amplitude variability, whereas the no
smoke, LV, and lAS sequences were characterized by high frequency with
low amplitude variability, consistent with random interframe noise. The mean
FFT centroid frequency for atrial smoke sequences (6.2 ± 2.7) was signifi-
cantly lower than the centroid frequency for no-smoke sequences (11.9 ±
4.1; P < 0.001). TotailBS variance (integral of all non-zero components) was
